Rua partners with Curaleaf in the UK
Rua is pleased to announce working with Curaleaf in the UK
Rua to Supply Medicinal MDMA in New Zealand
Capital Raise for Sales Growth
Annual Report & Shareholders Meeting
Rua commences direct distribution from Tairawhiti.
Traumatic Brain Injury Clinical Trial Funded
FY26 Financial Results: Significant Revenue Growth
Rua BIoscience Full Year Financial Results FY26
Rua enters into partnership with ancient plant
Five New Products Approved for New Zealand Market
Significant UK Distribution Agreement
Ruah Bioscience enters the UK market with a major distribution deal with a significant medicinal cannabis clinic and distribution company.
Introducing Oleo Panacea V2
Finalist in 2026 Cannabiz Awards
Europe update
Guide to Using Medicinal Cannabis in New Zealand
Market Update
Expansion into Canada with genetics export milestone
Half-Year Financial Results: Significant sales revenue growth
Rua BIoscience haf year financial results FY26
Investing in the Future of Tairawhiti: Rua Bioscience Scholarships
Darylene Rogers of Rua Bioscience acknowledges scholarship recipient Paimarire Heeney-Haua at the TKKM o Te Waiu o Ngati Porou prize giving 2025.
Successful rights offer is oversubscribed
Rua Bioscience rights offer outcome
